Nortadalafil-N-(2-hydroxy)propyl

CAS : 1353020-85-5

Ref. 3D-DEC02085

Informations sur le produit

• Nom: Nortadalafil-N-(2-hydroxy)propyl
• Marque: Biosynth
• Description: Nortadalafil-N-(2-hydroxy)propyl is a chemotherapeutic agent, which is synthesized through the chemical modification of tadalafil. It is characterized as a small-molecule inhibitor, derived from the structural alteration of the well-known phosphodiesterase type 5 (PDE5) inhibitor. The mechanism of action involves the attenuation of PDE5 activity, leading to increased levels of cyclic guanosine monophosphate (cGMP) within targeted cellular pathways. This elevation in cGMP concentration results in vasodilation and increased blood flow, primarily investigated within the context of vascular and erectile tissue.

Propriétés chimiques

• Masse moléculaire: 433.5 g/mol
• Formule: C₂₄H₂₃N₃O₅
• Degré de pureté: Min. 95%